Sitagliptin Defuoro IMpurity 3 Chemical Properties

Boiling point:

444.3±45.0 °C(Predicted)

Density 

1.243±0.06 g/cm3(Predicted)

storage temp. 

2-8°C

pka

4.37±0.10(Predicted)

Appearance

white solid

InChI

InChI=1/C15H19F2NO4/c1-15(2,3)22-14(21)18-11(8-13(19)20)6-9-4-5-10(16)7-12(9)17/h4-5,7,11H,6,8H2,1-3H3,(H,18,21)(H,19,20)/t11-/s3

InChIKey

LUYHWLQWAVCDNA-LBPXTSNRNA-N

SMILES

C(O)(=O)C[C@H](NC(OC(C)(C)C)=O)CC1=CC=C(F)C=C1F |&1:4,r|

Sitagliptin Defuoro IMpurity 3 Usage And Synthesis

Uses

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic Acid is a derivative of Sitagliptin (S491000), a dipeptidyl peptidase-4 inhibitor used to treat patients with type-2 diabetes by means of glycemic control.

Sitagliptin Defuoro IMpurity 3(851307-12-5)Related Product Information

• Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate
• Sitagliptin Impurity 14
• 1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)-
• (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
• rac-Sitagliptin EP Impurity B HCl
• Sitagliptin
• Sitagliptin Impurity 28
• Sitagliptin
• Duloxetine N-DesMethyl Metabolite
• 7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine
• Sitagliptin Defuoro IMpurity 4
• (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
• N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide
• (S)-Duloxetine SuccinaMide
• Methyl 3-aMino-4-(2,4,5-trifluorophenyl)butanoate
• Sitagliptin phosphate monohydrate
• 2,4,5-Trifluorobenzaldehyde
• Sitagliptin N-Phoshate IMpurity